LENZ Therapeutics Inc. (LENZ)
21.49
-0.05 (-0.23%)
At close: Mar 04, 2025, 1:12 PM
LENZ Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 185.86M | 47.73M | 376.98M | 19.82M | 6K |
| Short-Term Investments | n/a | 220.5M | n/a | n/a | n/a |
| Long-Term Investments | 114K | 17.04M | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 1.29M | 2.17M | -1 | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.16M | 2.2M | 4.76M | 1.29M | n/a |
| Total Current Assets | 188.02M | 275.37M | 381.74M | 21.1M | 6K |
| Property-Plant & Equipment | 321K | 28.21M | 18.08M | 1.46M | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 435K | 46.54M | 20.25M | 1.46M | n/a |
| Total Assets | 188.46M | 321.9M | 401.99M | 22.56M | 6K |
| Account Payables | 250K | 2.26M | 460K | 630K | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 285K | 103K | n/a | n/a | 2.21M |
| Other Current Liabilities | 4.26M | 10.33M | 11.68M | 31.42M | 19K |
| Total Current Liabilities | 4.8M | 13.04M | 12.14M | 32.05M | 2.22M |
| Long-Term Debt | 77K | 147K | n/a | n/a | n/a |
| Other Long-Term Liabilities | -1 | 12.42M | 31.3M | 316K | n/a |
| Total Long-Term Liabilities | 77K | 12.57M | 25.4M | 316K | n/a |
| Total Liabilities | 4.87M | 25.61M | 12.14M | 32.36M | 2.22M |
| Total Debt | 362K | 5.79M | n/a | n/a | 2.21M |
| Common Stock | 1K | 1K | 1K | n/a | n/a |
| Retained Earnings | -367.05M | -242.4M | -141.35M | -70.59M | -2.22M |
| Comprehensive Income | n/a | -1.05M | -999 | n/a | n/a |
| Shareholders Equity | 183.58M | 296.29M | 389.84M | -9.8M | -2.22M |
| Total Investments | 114K | 237.54M | n/a | n/a | n/a |